1型糖尿病成人每日步数分类与连续血糖监测指标之间的关联:T1DEXI队列分析
本研究为4周自由生活观察性研究,纳入464例1型糖尿病成人,按每日步数分为低于7000步、达到7000-10000步和超过10000步三组。结果显示,超过或达到步数目标当天的TIR均高于低于目标日(均75% vs 73%,均p<0.001),但超过目标日TBR也较高(3.1% vs 达到或低于目标日,差异分别为-0.3%和-0.4%),总日胰岛素剂量在超过或达到目标日低于低于目标日。
要点
- 超过或达到每日步数目标当天的TIR为75%,高于低于目标日的73%(p<0.001)。
- 超过步数目标日TBR为3.1%,高于达到或低于目标日(差异-0.3%和-0.4%)。
- 超过或达到步数目标日总日胰岛素剂量低于低于目标日(0.52或0.53 vs 0.55 U/kg)。
核心结论
- 与低步数日相比,较高步数日与TIR和TBR轻度升高以及总日胰岛素需求量小幅降低相关。
研究设计与样本
- 4周自由生活观察性研究,纳入464例有连续血糖监测和步数数据的1型糖尿病成人,按每日步数分为低于7000步、达到7000-10000步和超过10000步三组。
主要发现
- 参与者平均±SD年龄37±14岁,HbA1c 48.8±8.1 mmol/mol(6.6±0.7%),73%为女性,45%使用混合闭环系统,38%使用标准胰岛素泵,17%使用每日多次胰岛素注射。
- 组间分析显示,超过每日步数目标者TIR为75±14%,与达到目标者(74±14%)和低于目标者(75±16%)相似(p>0.05)。
- 组内比较显示,超过或达到步数目标日的TIR均为75±15%,高于低于目标日的73±16%(均p<0.001)。
- 超过步数目标日的TBR为3.1%±3.2%,高于达到或低于目标日(平均差异分别为-0.3%[p=0.006]和-0.4%[p=0.001])。
- 超过或达到步数目标日的总日胰岛素剂量分别为0.52±0.18 U/kg和0.53±0.18 U/kg,低于低于当前推荐步数日的0.55±0.18 U/kg(均p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Adults with type 1 diabetes should perform daily physical activity to help maintain health and fitness, but the influence of daily step counts on continuous glucose monitoring (CGM) metrics are unclear. This analysis used the Type 1 Diabetes Exercise Initiative (T1DEXI) dataset to investigate the effect of daily step count on CGM-based metrics. METHODS: In a 4 week free-living observational study of adults with type 1 diabetes, with available CGM and step count data, we categorised participants into three groups-below (<7000), meeting (7000-10,000) or exceeding (>10,000) the daily step count goal-to determine if step count category influenced CGM metrics, including per cent time in range (TIR: 3.9-10.0 mmol/l), time below range (TBR: <3.9 mmol/l) and time above range (TAR: >10.0 mmol/l). RESULTS: A total of 464 adults with type 1 diabetes (mean±SD age 37±14 years; HbA1c 48.8±8.1 mmol/mol [6.6±0.7%]; 73% female; 45% hybrid closed-loop system, 38% standard insulin pump, 17% multiple daily insulin injections) were included in the study. Between-participant analyses showed that individuals who exceeded the mean daily step count goal over the 4 week period had a similar TIR (75±14%) to those meeting (74±14%) or below (75±16%) the step count goal (p>0.05). In the within-participant comparisons, TIR was higher on days when the step count goal was exceeded or met (both 75±15%) than on days below the step count goal (73±16%; both p<0.001). The TBR was also higher when individuals exceeded the step count goals (3.1%±3.2%) than on days when they met or were below step count goals (difference in means -0.3% [p=0.006] and -0.4% [p=0.001], respectively). The total daily insulin dose was lower on days when step count goals were exceeded (0.52±0.18 U/kg; p<0.001) or were met (0.53±0.18 U/kg; p<0.001) than on days when step counts were below the current recommendation (0.55±0.18 U/kg). Step count had a larger effect on CGM-based metrics in participants with a baseline HbA1c ≥53 mmol/mol (≥7.0%). CONCLUSIONS/INTERPRETATION: Our results suggest that, compared with days with low step counts, days with higher step counts are associated with slight increases in both TIR and TBR, along with small reductions in total daily insulin requirements, in adults living with type 1 diabetes. DATA AVAILABILITY: The data that support the findings reported here are available on the Vivli Platform (ID: T1-DEXI; https://doi.org/10.25934/PR00008428 ).
引用
- Turner LV, Marak MC, Gal RL, et al. Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort. Diabetologia. 2024. PMID: 38502241. doi:10.1007/s00125-024-06127-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。